- Home
- BLZE vs PVLA Comparison
BLZE vs PVLA Comparison
Compare BLZE & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLZE
- PVLA
- Stock Information
- Founded
- BLZE 2007
- PVLA 2015
- Country
- BLZE United States
- PVLA United States
- Employees
- BLZE N/A
- PVLA N/A
- Industry
- BLZE Computer Software: Prepackaged Software
- PVLA Biotechnology: Pharmaceutical Preparations
- Sector
- BLZE Technology
- PVLA Health Care
- Exchange
- BLZE Nasdaq
- PVLA Nasdaq
- Market Cap
- BLZE 515.5M
- PVLA 604.2M
- IPO Year
- BLZE 2021
- PVLA N/A
- Fundamental
- Price
- BLZE $10.44
- PVLA $71.45
- Analyst Decision
- BLZE Strong Buy
- PVLA Strong Buy
- Analyst Count
- BLZE 8
- PVLA 12
- Target Price
- BLZE $10.31
- PVLA $68.67
- AVG Volume (30 Days)
- BLZE 498.2K
- PVLA 203.9K
- Earning Date
- BLZE 11-06-2025
- PVLA 11-15-2025
- Dividend Yield
- BLZE N/A
- PVLA N/A
- EPS Growth
- BLZE N/A
- PVLA N/A
- EPS
- BLZE N/A
- PVLA N/A
- Revenue
- BLZE $137,286,000.00
- PVLA N/A
- Revenue This Year
- BLZE $16.78
- PVLA N/A
- Revenue Next Year
- BLZE $13.98
- PVLA N/A
- P/E Ratio
- BLZE N/A
- PVLA N/A
- Revenue Growth
- BLZE 19.08
- PVLA N/A
- 52 Week Low
- BLZE $3.94
- PVLA $11.17
- 52 Week High
- BLZE $10.83
- PVLA $77.77
- Technical
- Relative Strength Index (RSI)
- BLZE 62.07
- PVLA 56.17
- Support Level
- BLZE $9.00
- PVLA $70.98
- Resistance Level
- BLZE $9.98
- PVLA $77.77
- Average True Range (ATR)
- BLZE 0.50
- PVLA 4.84
- MACD
- BLZE -0.05
- PVLA -0.47
- Stochastic Oscillator
- BLZE 95.49
- PVLA 46.24
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.